Lower Gastrointestinal Bleeding and Paroxetine Use: Two Case Reports

Psychosomatics

Volumn 53, Issue 2, 2012, Pages 184-187

  Blasco Fontecilla, Hilario ^a,b   De Leon, Jose ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Montpellier 1 University   (France)

^c EASTERN STATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; PAROXETINE; ANTIDEPRESSANT AGENT; DRUG DERIVATIVE; MIANSERIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONSTIPATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEMORRHOID; HUMAN; MAJOR DEPRESSION; MALE; PANIC; RISK FACTOR; TREMOR; BLOOD; BLOOD CLOTTING TEST; CHEMICALLY INDUCED DISORDER; DEPRESSION; DRUG COMBINATION;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD COAGULATION TESTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMANS; MALE; MIANSERIN; PANIC DISORDER; PAROXETINE; TREMOR; YOUNG ADULT;

EID: 84863828525     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2011.09.002     Document Type: Article

References (20)

1. Andrade C., Sandarsh S., Chethan K.B., Nagesh K.S. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010, 71:1565-1575.
2. Schlienger R.G., Fischer L.M., Jick H., Meier C.R. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf 2004, 27:1157-1165.
3. Ottervanger J.P., Stricker B.H., Huls J., Weeda J.N. Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994, 151:781-782.
4. de Abajo F.J., Montero D., Rodriguez L.A., Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 2006, 98:304-310.
5. Ahsberg K., Hoglund P., Kim W.H., von Holstein C.S. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding. Scand J Gastroenterol 2010, 45:1404-1415.
6. Imdahl A. Genesis and pathophysiology of lower gastrointestinal bleeding. Langenbecks Arch Surg 2001, 386:1-7.
7. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30:239-245.
8. Carvajal A., Ortega S., Del Olmo L., Vidal X., Aguirre C., Ruiz C., et al. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study. PLoS One 2011, 6:e19819.
9. Wessinger S., Kaplan M., Choi L., Williams M., Lau C., Sharp L., et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006, 23:937-944.
10. Narayan M., Anderson G., Cellar J., Mallison R.T., Price L.H., Nelson J.C. Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin. J Clin Psychopharmacol 1998, 18:67-71.
11. Hergovich N., Aigner M., Eichler H.G., Entlicher J., Drucker C., Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000, 68:435-442.
12. Abdelmalik N., Ruhe H.G., Barwari K., van den Dool E.J., Meijers J.C., Middeldorp S., et al. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost 2008, 6:2168-2174.
13. Wgner A., Montero D., Martensson B., Siwers B., Asberg M. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J Affect Disord 1990, 20:101-113.
14. Halperin D., Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 2007, 9:47-59.
15. Hougardy D.M., Egberts T.C., van der Graaf F., Brenninkmeijer V.J., Derijks L.J. Serotonin transporter polymorphism and bleeding time during SSRI therapy. Br J Clin Pharmacol 2008, 65:761-766.
16. Brown P., Faloon L. The incidence and reporting of adverse drug reactions in the division of psychiatry. Pharm World Sci 2001, 23:181-182.
17. Tuninger E., Levander S. Neuropsychological impairment in patients treated with depot neuroleptics: a longitudinal study. Acta Psychiatr Scand 2001, (Suppl 408):75-80.
18. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987, (Suppl 334):1-100.
19. Tebruegge M., Misra I., Pantazidou A., Padhye A., Maity S., Dwarakanathan B., et al. Estimating blood loss: comparative study of the accuracy of parents and health care professionals. Pediatrics 2009, 124:e729-e736.
20. Kose G., Arhan E., Unal B., Ozaydin E., Guven A., Sayli T.R. Valproate-associated coagulopathies in children during short-term treatment. J Child Neurol 2009, 24:1493-1498.